Healthcare Economics & Policy

CMS proposed to expand reimbursement for ambulatory blood pressure monitoring (ABPM) to patients with suspected masked hypertension while continuing to cover it for those with white coat hypertension.

Three physicians published an editorial in Stroke proposing that tertiary healthcare centers in cities be held to stricter standards for performing endovascular thrombectomy (EVT) than their rural counterparts.

Several professional medical societies have now weighed in on a bill introduced to Congress on April 9 which seeks to prevent physicians from self-referring Medicare patients to in-office “ancillary services” including advanced imaging, anatomic pathology, radiation therapy and physical therapy.

The FDA’s decision to mandate labeling of added sugar content on packaged foods and beverages is estimated to prevent nearly 1 million cases of diabetes and cardiovascular disease over the next 20 years and save the U.S. $31 billion in net healthcare costs over that timeframe.

An April 2 story in the New York Times highlighted a potentially dangerous insurance coverage gap faced by heart transplant patients and recipients of other organs—the immunosuppressive drugs they need to prevent organ rejection sometimes aren’t covered by Medicare if they received the transplants before enrolling in the program.

French drugmaker Sanofi announced on April 10 a plan to lower its insulin prices to $99 per month for some U.S. patients, beginning in June. The announcement came amid a series of congressional hearings about drug costs and was met with questions about why this move and other recent cost-cutting measures took so long.

Cardiologists earn the fourth-most money of any medical specialty, according to Medscape’s 2019 physician compensation report, bringing in an average of $430,000 each year.

A study of nearly 900,000 patients with heart failure or cardiogenic shock revealed their race, insurance coverage and ZIP code were associated with their odds of receiving a left ventricular assist device (LVAD).

Medtronic has struck a value-based agreement with Blue Cross and Blue Shield of Minnesota in which the medical device company will pay back the insurer if patients using the Guardian Connect continuous glucose monitoring (CGM) system fail to keep their blood sugar levels within a specified range.

Dietary risk factors—such as consuming too much sodium or not enough whole grains and fruits—were responsible for 11 million deaths globally in 2017, according to a new analysis in The Lancet.

The actual cost of a heart attack or stroke to society is about double the direct medical costs when lost productivity for patients and caregivers is considered, according to a study published April 6 in the European Journal of Preventive Cardiology.

Counties in states that expanded Medicaid coverage under the Affordable Care Act (ACA) had fewer deaths from cardiovascular disease than those in states that didn’t expand Medicaid, according to an abstract presented April 5 at the American Heart Association’s Quality of Care and Outcomes Research scientific sessions.